NYSE - Nasdaq Real Time Price USD

Inspire Medical Systems, Inc. (INSP)

232.77 -8.38 (-3.48%)
As of 1:54 PM EDT. Market Open.
Loading Chart for INSP
DELL
  • Previous Close 241.15
  • Open 242.23
  • Bid --
  • Ask --
  • Day's Range 230.16 - 244.62
  • 52 Week Range 123.27 - 330.00
  • Volume 249,051
  • Avg. Volume 509,353
  • Market Cap (intraday) 7.052B
  • Beta (5Y Monthly) 1.40
  • PE Ratio (TTM) --
  • EPS (TTM) -0.72
  • Earnings Date May 7, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 252.87

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

www.inspiresleep.com

1,011

Full Time Employees

December 31

Fiscal Year Ends

Recent News: INSP

Performance Overview: INSP

Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

INSP
14.42%
S&P 500
4.79%

1-Year Return

INSP
11.32%
S&P 500
20.30%

3-Year Return

INSP
0.57%
S&P 500
19.42%

5-Year Return

INSP
394.52%
S&P 500
72.05%

Compare To: INSP

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: INSP

Valuation Measures

As of 4/19/2024
  • Market Cap

    7.31B

  • Enterprise Value

    6.87B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    11.31

  • Price/Book (mrq)

    12.76

  • Enterprise Value/Revenue

    11.00

  • Enterprise Value/EBITDA

    -402.74

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -3.39%

  • Return on Assets (ttm)

    -4.05%

  • Return on Equity (ttm)

    -3.96%

  • Revenue (ttm)

    624.8M

  • Net Income Avi to Common (ttm)

    -21.15M

  • Diluted EPS (ttm)

    -0.72

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    460.38M

  • Total Debt/Equity (mrq)

    4.34%

  • Levered Free Cash Flow (ttm)

    380.62k

Research Analysis: INSP

Analyst Price Targets

187.00 Low
252.87 Average
232.77 Current
280.00 High
 

Fair Value

Overvalued
% Return
232.77 Current
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

People Also Watch